Get your target dose from a licensed provider this calculator handles the arithmetic, not the protocol
Patients interested in access should speak with their GP or obesity medicine specialist about eligibility for ongoing MHRA-authorised clinical trials
doi: 10.1016/j.molmet.2019.07.008 Summary Keywords metabolic dysfunction-associated fatty liver disease (MASLD), non-alcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (T2DM), insulin resistance (IR), hepatic steatosis, lipotoxicity, inflammation, adipokines Citation Mohiuddin MS, Neha NT, Mahir JUK, Shakib FAF, Alam MA, Wahiduzzaman M, Barua R, Shimu SJ, Rahman M, Hossain MR, Shariare MH, Mohib MM and Uddin MB (2025) Metabolic dysfunction associated fatty liver disease and type 2 diabetes: pathophysiological links, epidemiological trends, and clinical implications
However, unlike prescription based GLP-1 agonists like Ozempic, Lemme GLP-1 Daily does not contain synthetic GLP-1 hormone and is not a GLP-1 agonist drug, a press release from the company clarifies
